Standard: Human intestinal cancer organoids
Abstract Intestinal cancer is one of the most frequent and lethal types of cancer. Modeling intestinal cancer using organoids has emerged in the last decade. Human intestinal cancer organoids are physiologically relevant in vitro models, which provides an unprecedented opportunity for fundamental an...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2023-06-01
|
| Series: | Cell Regeneration |
| Online Access: | https://doi.org/10.1186/s13619-023-00167-6 |
| _version_ | 1797789687241244672 |
|---|---|
| author | Hanqing Lin Yalong Wang Chunyan Cheng Yuxin Qian Jie Hao Zhen Zhang Weiqi Sheng Linhong Song Chu-Xia Deng Bing Zhao Jiani Cao Lei Wang Liu Wang Lingmin Liang Wenli Kelly Chen Chunping Yu Zhijian Sun Yingying Yang Changlin Wang Yong Zhang Qiyuan Li Ka Li Aijin Ma Tongbiao Zhao Ye-Guang Chen Guoqiang Hua |
| author_facet | Hanqing Lin Yalong Wang Chunyan Cheng Yuxin Qian Jie Hao Zhen Zhang Weiqi Sheng Linhong Song Chu-Xia Deng Bing Zhao Jiani Cao Lei Wang Liu Wang Lingmin Liang Wenli Kelly Chen Chunping Yu Zhijian Sun Yingying Yang Changlin Wang Yong Zhang Qiyuan Li Ka Li Aijin Ma Tongbiao Zhao Ye-Guang Chen Guoqiang Hua |
| author_sort | Hanqing Lin |
| collection | DOAJ |
| description | Abstract Intestinal cancer is one of the most frequent and lethal types of cancer. Modeling intestinal cancer using organoids has emerged in the last decade. Human intestinal cancer organoids are physiologically relevant in vitro models, which provides an unprecedented opportunity for fundamental and applied research in colorectal cancer. “Human intestinal cancer organoids” is the first set of guidelines on human intestinal organoids in China, jointly drafted and agreed by the experts from the Chinese Society for Cell Biology and its branch society: the Chinese Society for Stem Cell Research. This standard specifies terms and definitions, technical requirements, test methods for human intestinal cancer organoids, which apply to the production and quality control during the process of manufacturing and testing of human intestinal cancer organoids. It was released by the Chinese Society for Cell Biology on 24 September 2022. We hope that the publication of this standard will guide institutional establishment, acceptance and execution of proper practocal protocols, and accelerate the international standardization of human intestinal cancer organoids for clinical development and therapeutic applications. |
| first_indexed | 2024-03-13T01:54:13Z |
| format | Article |
| id | doaj.art-26a5684557e44f23b9d27f6534aa642f |
| institution | Directory Open Access Journal |
| issn | 2045-9769 |
| language | English |
| last_indexed | 2024-03-13T01:54:13Z |
| publishDate | 2023-06-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Cell Regeneration |
| spelling | doaj.art-26a5684557e44f23b9d27f6534aa642f2023-07-02T11:17:51ZengSpringerOpenCell Regeneration2045-97692023-06-011211610.1186/s13619-023-00167-6Standard: Human intestinal cancer organoidsHanqing Lin0Yalong Wang1Chunyan Cheng2Yuxin Qian3Jie Hao4Zhen Zhang5Weiqi Sheng6Linhong Song7Chu-Xia Deng8Bing Zhao9Jiani Cao10Lei Wang11Liu Wang12Lingmin Liang13Wenli Kelly Chen14Chunping Yu15Zhijian Sun16Yingying Yang17Changlin Wang18Yong Zhang19Qiyuan Li20Ka Li21Aijin Ma22Tongbiao Zhao23Ye-Guang Chen24Guoqiang Hua25D1Med Technology (Shanghai) IncThe State Key Laboratory of Membrane Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua UniversityD1Med Technology (Shanghai) IncD1Med Technology (Shanghai) IncNational Stem Cell Resource Center, State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, Chinese Academy of SciencesDepartment of Radiation Oncology and Cancer Institute, Fudan University Shanghai Cancer Center Fudan UniversityDepartment of Oncology, Shanghai Medical College, Fudan UniversitySichuan Academy of Medical Sciences & Sichuan Provincial People’s HospitalCancer Centre, Faculty of Health Sciences, University of MacauState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan UniversityNational Stem Cell Resource Center, State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, Chinese Academy of SciencesNational Stem Cell Resource Center, State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, Chinese Academy of SciencesNational Stem Cell Resource Center, State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, Chinese Academy of SciencesNational Stem Cell Resource Center, State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, Chinese Academy of SciencesChina Innovation Center of RocheEli Lilly and CompanyK2 Oncology Co., LtdQilu Pharmaceutical Co., LtdChina National Institute of StandardizationChinese Society for Stem Cell ResearchInstitute of Clinical Science, Zhongshan Hospital, Fudan UniversityInstitute of Clinical Science, Zhongshan Hospital, Fudan UniversityInstitute of Clinical Science, Zhongshan Hospital, Fudan UniversityNational Stem Cell Resource Center, State Key Laboratory of Stem Cell and Reproductive Biology, Institute for Stem Cell and Regeneration, Institute of Zoology, Chinese Academy of SciencesThe State Key Laboratory of Membrane Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua UniversityD1Med Technology (Shanghai) IncAbstract Intestinal cancer is one of the most frequent and lethal types of cancer. Modeling intestinal cancer using organoids has emerged in the last decade. Human intestinal cancer organoids are physiologically relevant in vitro models, which provides an unprecedented opportunity for fundamental and applied research in colorectal cancer. “Human intestinal cancer organoids” is the first set of guidelines on human intestinal organoids in China, jointly drafted and agreed by the experts from the Chinese Society for Cell Biology and its branch society: the Chinese Society for Stem Cell Research. This standard specifies terms and definitions, technical requirements, test methods for human intestinal cancer organoids, which apply to the production and quality control during the process of manufacturing and testing of human intestinal cancer organoids. It was released by the Chinese Society for Cell Biology on 24 September 2022. We hope that the publication of this standard will guide institutional establishment, acceptance and execution of proper practocal protocols, and accelerate the international standardization of human intestinal cancer organoids for clinical development and therapeutic applications.https://doi.org/10.1186/s13619-023-00167-6 |
| spellingShingle | Hanqing Lin Yalong Wang Chunyan Cheng Yuxin Qian Jie Hao Zhen Zhang Weiqi Sheng Linhong Song Chu-Xia Deng Bing Zhao Jiani Cao Lei Wang Liu Wang Lingmin Liang Wenli Kelly Chen Chunping Yu Zhijian Sun Yingying Yang Changlin Wang Yong Zhang Qiyuan Li Ka Li Aijin Ma Tongbiao Zhao Ye-Guang Chen Guoqiang Hua Standard: Human intestinal cancer organoids Cell Regeneration |
| title | Standard: Human intestinal cancer organoids |
| title_full | Standard: Human intestinal cancer organoids |
| title_fullStr | Standard: Human intestinal cancer organoids |
| title_full_unstemmed | Standard: Human intestinal cancer organoids |
| title_short | Standard: Human intestinal cancer organoids |
| title_sort | standard human intestinal cancer organoids |
| url | https://doi.org/10.1186/s13619-023-00167-6 |
| work_keys_str_mv | AT hanqinglin standardhumanintestinalcancerorganoids AT yalongwang standardhumanintestinalcancerorganoids AT chunyancheng standardhumanintestinalcancerorganoids AT yuxinqian standardhumanintestinalcancerorganoids AT jiehao standardhumanintestinalcancerorganoids AT zhenzhang standardhumanintestinalcancerorganoids AT weiqisheng standardhumanintestinalcancerorganoids AT linhongsong standardhumanintestinalcancerorganoids AT chuxiadeng standardhumanintestinalcancerorganoids AT bingzhao standardhumanintestinalcancerorganoids AT jianicao standardhumanintestinalcancerorganoids AT leiwang standardhumanintestinalcancerorganoids AT liuwang standardhumanintestinalcancerorganoids AT lingminliang standardhumanintestinalcancerorganoids AT wenlikellychen standardhumanintestinalcancerorganoids AT chunpingyu standardhumanintestinalcancerorganoids AT zhijiansun standardhumanintestinalcancerorganoids AT yingyingyang standardhumanintestinalcancerorganoids AT changlinwang standardhumanintestinalcancerorganoids AT yongzhang standardhumanintestinalcancerorganoids AT qiyuanli standardhumanintestinalcancerorganoids AT kali standardhumanintestinalcancerorganoids AT aijinma standardhumanintestinalcancerorganoids AT tongbiaozhao standardhumanintestinalcancerorganoids AT yeguangchen standardhumanintestinalcancerorganoids AT guoqianghua standardhumanintestinalcancerorganoids |